Factor VIII products in haemophilia A: one size fits all?

Affiliations

Editorial

Pier Mannuccio Mannucci et al. Thromb Haemost. 2015 May.

. 2015 May;113(5):911-4.

doi: 10.1160/TH15-04-0273. Epub 2015 Apr 9.

¹ P. M. Mannucci, Via Pace 9, 20122 Milano, Italy, Tel.: +39 02 55038377, Fax: +39 02 50320723, E-mail: piermannuccio.mannucci@policlinico.mi.it.

No abstract available

Comment on

Inhibitor development in haemophilia according to concentrate. Four-year results from the European HAemophilia Safety Surveillance (EUHASS) project.
Fischer K, Lassila R, Peyvandi F, Calizzani G, Gatt A, Lambert T, Windyga J, Iorio A, Gilman E, Makris M; EUHASS participants. Fischer K, et al. Thromb Haemost. 2015 May;113(5):968-75. doi: 10.1160/TH14-10-0826. Epub 2015 Jan 8. Thromb Haemost. 2015. PMID: 25567324
Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A. A patient-level meta-analysis.
Marcucci M, Mancuso ME, Santagostino E, Kenet G, Elalfy M, Holzhauer S, Bidlingmaier C, Escuriola Ettingshausen C, Iorio A, Nowak-Göttl U. Marcucci M, et al. Thromb Haemost. 2015 May;113(5):958-67. doi: 10.1160/TH14-07-0621. Epub 2015 Jan 29. Thromb Haemost. 2015. PMID: 25631402